1 / 8

Global Oncology Drugs Market Report And Strategies To 2032

TBRC oncology drugs market report includes lung cancer, pancreatic cancer, breast cancer, prostate cancer, ovarian cancer, colorectal cancer, gastric cancer, kidney cancer, brain tumor, thyroid cancer,<br>

Download Presentation

Global Oncology Drugs Market Report And Strategies To 2032

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Oncology Drugs Market 2023 Market Size, Trends and Global Forecast 2023-2032 © The Business Research Company. All Rights Reserved.

  2. Point-of-Use Oncology Drugs Market Segments The Business Research Company segments it’s Point-of-Use Oncology Drugs Market report as: The blood cancer was the largest segment of the oncology drugs market by type, accounting for $43.47 billion or 19.5% of the total market in 2022. The ovarian cancer market is expected to be the fastest-growing segment going forward at a CAGR of 18.5%. By Type The hospital pharmacies was the largest segment of the oncology drugs market by distribution channel, accounting for $123.10 billion or 55.1% of the total market in 2022. The other distribution channel market is expected to be the fastest-growing segment going forward at a CAGR of 7.9%. By Distribution Channel By Route Of Administration - The oral was the largest segment of the oncology drugs market by route of administration, accounting for $123.50 billion or 55.3% of the total market in 2022. The oral market is expected to be the fastest-growing segment going forward at a CAGR of 7.6%. © The Business Research Company. All Rights Reserved.

  3. Point-of-Use Oncology Drugs Market Statistics The global oncology drugs market grew from $223.34 billion in 2022, having increased at a compound annual growth rate (CAGR) of 6.5 % since 2017. The market is expected to grow from $223.34 billion in 2022 to $318.31 billion in 2027 at a rate of 7.3 %. The market is then expected to grow at a CAGR of 6.9% from 2027 and reach $445.23 billion in 2032. Global Point-of-Use Oncology Drugs Market Size Forecast To 2032 Series 1, 2032, 445.23 y = 110.95x + 107.07 R² = 0.9931 Series 1, 2027, 318.31 Series 1, 2022, 223.34 Click Here To Get A Sample Report © The Business Research Company. All Rights Reserved.

  4. Key Market Drivers And Trends Drivers The rise in the number of cancer cases across the globe is likely to contribute to the growth of the oncology drugs market during the forecast period. Trends Companies in the oncology drugs market are increasingly investing in technologies such as artificial intelligence (AI) to save time and reduce research and development costs. Region North America was the largest region in the oncology drugs market, accounting for 43.2% of the global market in 2022. © The Business Research Company. All Rights Reserved.

  5. Key Market Players Major players in the Point-of-Use Oncology Drugs Market are:  Bristol-Myers Squibb Company Limited  F. Hoffmann-La Roche AG  Merck & Co. Inc.  Novartis AG  Johnson & Johnson Get More Information On The Point-of-Use Oncology Drugs Market Report © The Business Research Company. All Rights Reserved.

  6. 5 Reasons Why TBRC Is The Solution You Need 1. Measure the impact of high global inflation on market growth 2. Outperform competitors using forecast data and the drivers and trends shaping the market 3. Get a comprehensive market sizing report with a truly global perspective covering 60+ geographies from The Business Research Company, with data from 2017 to 2023 and forecasts up to 2032. 4. Assess the Russia-Ukraine war’s impact on commodity supply and its direct and indirect impact on all the markets 5. Benchmark performance against key competitors. © The Business Research Company. All Rights Reserved.

  7. Americas The Business Research Company, 1295 N Providence Rd, Media, PA 19063, USA ✆ ✆ +1 3156230293 Get In Touch Europe The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE How ever you want to grow and expand, The Business Research Company can help as we provide research consulting solutions for businesses, government agencies consultancies, and market research companies. ✆ ✆ +44 207 1930 708 Asia The Business Research Company, 1st Floor, Anshu Colors Building, Road Number 1, Park View Enclave, Jubilee Hills, Hyderabad (India), 500033 info@tbrc.info ✆ ✆ +91 8897263534 @The Business Research Company. All rights reserved. © The Business Research Company. All Rights Reserved.

  8. Your Growth Insights Partner © The Business Research Company. All Rights Reserved.

More Related